Evidence map›Paper›PMID 41127781›Full record

ArticleCureus2025

Penile Pseudomyogenic Hemangioendothelioma: Diagnostic and Therapeutic Considerations.

Ameer Nsair, Etan Eigner, Inbal Farkash, Valentine Shabataev, Ariel Zisman

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ameer NsairUrology, Rambam Medical Center, Haifa, ISR.
Etan EignerUrology, Rambam Medical Center, Haifa, ISR.
Inbal FarkashPathology, Rambam Medical Center, Haifa, ISR.
Valentine ShabataevUrology, Rambam Medical Center, Haifa, ISR.
Ariel ZismanUrology, Rambam Health Care Campus, Haifa, ISR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomyogenic hemangioendothelioma (PHE) is a rare vascular tumor of low-grade malignancy, most commonly affecting the limbs of young males. Its occurrence in the penis is extremely uncommon. We present a case of a 19-year-old male with a one-year history of a painful penile mass. Imaging and histopathology confirmed the diagnosis of PHE localized to the right corpus cavernosum, with partial involvement of the left side. Preoperative planning included MRI with pharmacologically induced erection and 3D modeling. Reconstructive organ-sparing surgery was performed, involving excision of the midportion of the right corpora cavernosa and partial excision of the left, followed by reconstruction using a bovine pericardial graft. At the six-month follow-up, no recurrence of the disease was observed on PET-CT, and the patient exhibited preserved urinary and erectile function, with moderate right-sided curvature. A minor revision procedure was required due to graft infection. This report highlights the diagnostic and therapeutic challenges associated with penile PHE. A multidisciplinary approach incorporating advanced imaging and 3D modeling can facilitate function-preserving surgery with satisfactory short-term outcomes.

Indexed as

3d modelingmri penisorgan-sparing surgerypseudomyogenic hemangioendotheliomarare vascular tumor­reconstructive surgery

Identifiers

PMID41127781
PMCPMC12539655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.